Back to User profile » Dr Xingang Li
Papers published by Dr Xingang Li:
Original Research
Hematological Safety of Contezolid versus Linezolid in Stage 5 Chronic Kidney Disease: An Active-Comparator New-User Retrospective Cohort Study
Zhang W, Cai X, Hou R, Guo J, Ma Y, Kang J, Li X
Drug Design, Development and Therapy 2026, 20:576881
Published Date: 30 January 2026
Original Research
Real-World Analysis of Potential Drug-Drug Interactions with Nirmatrelvir/Ritonavir Based on the Hospital Prescription Analysis (HPA) Database in 9 Cities of China
Guo H, Zhou Y, Li X, Zheng Y, Li Z, Liu Y, Li D
Infection and Drug Resistance 2025, 18:4539-4548
Published Date: 29 August 2025
Original Research
PEAR1, PON1, CYP2C19, CYP1A2 and F2R Polymorphisms are Associated with MACE in Clopidogrel-Treated Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
Du P, Li X, Li D, Ma Y, Ni M, Li Y, Li W, Wang A, Xu X
Pharmacogenomics and Personalized Medicine 2024, 17:611-621
Published Date: 21 December 2024
Case report
Immune-Related Colitis Induced by Camrelizumab: A Case Report
Cheng S, Yang Y, Yu J, Chen W, Li X
Journal of Inflammation Research 2023, 16:1727-1731
Published Date: 18 April 2023
Original Research
Assessment of patients’ warfarin knowledge and anticoagulation control at a joint physician- and pharmacist-managed clinic in China
Li X, Sun S, Wang Q, Chen B, Zhao Z, Xu X
Patient Preference and Adherence 2018, 12:783-791
Published Date: 9 May 2018